Science 37 Holdings, Inc.
SNCE · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $1 | $0 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $0 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -3% | 9% | -11.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 39.7% | 35.1% | 21.1% | 22.9% |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -22% | -14% | -68% | 180.6% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -93.5% | -127.5% | -166.9% | -417.4% |
| EPS Diluted | -0.12 | -0.17 | -0.2 | -0.57 |
| % Growth | 29.4% | 15% | 64.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |